{"@context":{"@vocab":"https://schema.org/"},"@type":"Drug","@id":"https://api.morvs.ai/drug-product/0003-7125#drug","name":"OPDUALAG","alternateName":"nivolumab and relatlimab-rmbw","identifier":[{"@type":"PropertyValue","propertyID":"FDA National Drug Code (NDC)","value":"0003-7125"},{"@type":"PropertyValue","propertyID":"FDA application number","value":"BLA761234"},{"@type":"PropertyValue","propertyID":"UNII","value":"31YO63LBSN|AF75XOF6W3"},{"@type":"PropertyValue","propertyID":"SPL Set ID","value":"b22c9d83-3256-4e17-85f7-f331a504adc6"}],"activeIngredient":"NIVOLUMAB, RELATLIMAB","administrationRoute":["INTRAVENOUS"],"dosageForm":"INJECTION","manufacturer":{"@type":"Organization","name":"E.R. Squibb & Sons, L.L.C."},"drugClass":[],"isAvailableGenerically":false,"legalStatus":"HUMAN PRESCRIPTION DRUG","sameAs":["https://api.morvs.ai/drug-approval/BLA761234","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=b22c9d83-3256-4e17-85f7-f331a504adc6","https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=0003-7125"],"isAccessibleForFree":true,"license":"https://creativecommons.org/publicdomain/zero/1.0/","_source":{"data_provider":"AI Analytics","brand_name":"MORVS","brand_url":"https://morvs.ai/","data_provider_url":"https://api.morvs.ai","license":"https://creativecommons.org/publicdomain/zero/1.0/","primary_source":"https://open.fda.gov/apis/drug/ndc/","generated_at":"2026-11-03T08:58:02.182Z"}}